Go Pro

MarketBeat Instant News Alerts

LTC Properties logo with Real Estate background

Huntington Begins Coverage on LTC Properties (NYSE:LTC)

Huntington began coverage on LTC Properties in a research note on Thursday. They issued an "outperform" rating and a $47.00 price target for the company.

NYSE:LTC
Read Huntington Begins Coverage on LTC Properties (NYSE:LTC)
National Health Investors logo with Real Estate background

National Health Investors (NYSE:NHI) Coverage Initiated by Analysts at Huntington

Huntington began coverage on National Health Investors in a research report on Thursday. They issued an "outperform" rating and a $79.00 price target on the stock.

NYSE:NHI
Read National Health Investors (NYSE:NHI) Coverage Initiated by Analysts at Huntington
Global Medical REIT logo with Real Estate background

Global Medical REIT (NYSE:XRN) Earns Market Perform Rating from Analysts at Huntington

Huntington began coverage on shares of Global Medical REIT in a research note on Thursday. They set a "market perform" rating and a $37.00 target price on the stock.

NYSE:XRN
Read Global Medical REIT (NYSE:XRN) Earns Market Perform Rating from Analysts at Huntington
BioCryst Pharmaceuticals logo with Healthcare background

BioCryst Pharmaceuticals (NASDAQ:BCRX) Stock Rating Lowered by Royal Bank Of Canada

Royal Bank Of Canada downgraded BioCryst Pharmaceuticals from an "outperform" rating to a "sector perform" rating and set a $11.00 price objective on the stock. in a research note on Thursday.

NASDAQ:BCRX
Read BioCryst Pharmaceuticals (NASDAQ:BCRX) Stock Rating Lowered by Royal Bank Of Canada
Fatpipe Inc/UT logo with Technology background

Fatpipe Inc/UT (NASDAQ:FATN) Now Covered by Roth Capital

Roth Capital started coverage on shares of Fatpipe Inc/UT in a research note on Thursday. They issued a "buy" rating and a $8.00 target price for the company.

NASDAQ:FATN
Read Fatpipe Inc/UT (NASDAQ:FATN) Now Covered by Roth Capital
Opus Genetics logo with Healthcare background

Opus Genetics (NASDAQ:IRD) Given New $13.00 Price Target at Wedbush

Wedbush upped their price objective on Opus Genetics from $10.00 to $13.00 and gave the company an "outperform" rating in a research report on Thursday.

NASDAQ:IRD
Read Opus Genetics (NASDAQ:IRD) Given New $13.00 Price Target at Wedbush

Trending News

All MarketBeat Instant News Alerts

Saia logo with Industrials background

Saia (NASDAQ:SAIA) Now Covered by Sanford C. Bernstein

NASDAQ:SAIA
Read Saia (NASDAQ:SAIA) Now Covered by Sanford C. Bernstein
Sabra Healthcare REIT logo with Real Estate background

Sabra Healthcare REIT (NASDAQ:SBRA) Now Covered by Huntington

NASDAQ:SBRA
Read Sabra Healthcare REIT (NASDAQ:SBRA) Now Covered by Huntington
ServiceNow logo with Technology background

ServiceNow Maps AI Control Tower Strategy as Agents, Security Drive Growth

NYSE:NOW
Read ServiceNow Maps AI Control Tower Strategy as Agents, Security Drive Growth
Chewy logo with Consumer Discretionary background

Chewy's (CHWY) Market Outperform Rating Reiterated at Citizens Jmp

NYSE:CHWY
Read Chewy's (CHWY) Market Outperform Rating Reiterated at Citizens Jmp
Bowhead Specialty logo with Finance background

Bowhead Specialty (NYSE:BOW) Receives Market Perform Rating from Citizens Jmp

NYSE:BOW
Read Bowhead Specialty (NYSE:BOW) Receives Market Perform Rating from Citizens Jmp
BitMine Immersion Technologies logo with Finance background

BitMine Immersion Technologies (NYSE:BMNR) Given New $63.60 Price Target at Cantor Fitzgerald

NYSE:BMNR
Read BitMine Immersion Technologies (NYSE:BMNR) Given New $63.60 Price Target at Cantor Fitzgerald
Caterpillar logo with Industrials background

Caterpillar (NYSE:CAT) Upgraded at Freedom Broker

NYSE:CAT
Read Caterpillar (NYSE:CAT) Upgraded at Freedom Broker
Cypherpunk Technologies logo with Healthcare background

Cantor Fitzgerald Boosts Cypherpunk Technologies (NASDAQ:CYPH) Price Target to $4.90

NASDAQ:CYPH
Read Cantor Fitzgerald Boosts Cypherpunk Technologies (NASDAQ:CYPH) Price Target to $4.90
DNOW logo with Industrials background

Freedom Broker Reiterates Hold Rating for DNOW (NYSE:DNOW)

NYSE:DNOW
Read Freedom Broker Reiterates Hold Rating for DNOW (NYSE:DNOW)
SK hynix logo with Technology background

SK hynix (NASDAQ:SKHY) Coverage Initiated by Analysts at JPMorgan Chase & Co.

NASDAQ:SKHY
Read SK hynix (NASDAQ:SKHY) Coverage Initiated by Analysts at JPMorgan Chase & Co.
Meta Platforms logo with Communication Services background

Meta Platforms (NASDAQ:META) Raised to Overweight at JPMorgan Chase & Co.

NASDAQ:META
Read Meta Platforms (NASDAQ:META) Raised to Overweight at JPMorgan Chase & Co.
Hyperliquid Strategies logo with Industrials background

Hyperliquid Strategies (NASDAQ:PURR) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says

NASDAQ:PURR
Read Hyperliquid Strategies (NASDAQ:PURR) Stock Price Expected to Rise, Cantor Fitzgerald Analyst Says
United Rentals logo with Industrials background

JPMorgan Chase & Co. Reiterates Neutral Rating for United Rentals (NYSE:URI)

NYSE:URI
Read JPMorgan Chase & Co. Reiterates Neutral Rating for United Rentals (NYSE:URI)
Sharplink Gaming logo with Finance background

Cantor Fitzgerald Forecasts Strong Price Appreciation for Sharplink Gaming (NASDAQ:SBET) Stock

NASDAQ:SBET
Read Cantor Fitzgerald Forecasts Strong Price Appreciation for Sharplink Gaming (NASDAQ:SBET) Stock
Herc logo with Industrials background

Herc (NYSE:HRI) Stock Rating Upgraded by JPMorgan Chase & Co.

NYSE:HRI
Read Herc (NYSE:HRI) Stock Rating Upgraded by JPMorgan Chase & Co.
Upexi logo with Finance background

Cantor Fitzgerald Boosts Upexi (NASDAQ:UPXI) Price Target to $2.00

NASDAQ:UPXI
Read Cantor Fitzgerald Boosts Upexi (NASDAQ:UPXI) Price Target to $2.00
Shoe Carnival logo with Consumer Discretionary background

Shoe Carnival (NASDAQ:SHOE) Releases FY 2026 Earnings Guidance

NASDAQ:SHOE
Read Shoe Carnival (NASDAQ:SHOE) Releases FY 2026 Earnings Guidance
Macy's logo with Consumer Discretionary background

Macy's (NYSE:M) Updates FY 2026 Earnings Guidance

NYSE:M
Read Macy's (NYSE:M) Updates FY 2026 Earnings Guidance
Macy's logo with Consumer Discretionary background

Macy's (NYSE:M) Issues Q3 2026 Earnings Guidance

NYSE:M
Read Macy's (NYSE:M) Issues Q3 2026 Earnings Guidance
Lovesac logo with Consumer Discretionary background

Lovesac (NASDAQ:LOVE) Updates FY 2027 Earnings Guidance

NASDAQ:LOVE
Read Lovesac (NASDAQ:LOVE) Updates FY 2027 Earnings Guidance
Lovesac logo with Consumer Discretionary background

Lovesac (NASDAQ:LOVE) Updates Q3 2027 Earnings Guidance

NASDAQ:LOVE
Read Lovesac (NASDAQ:LOVE) Updates Q3 2027 Earnings Guidance
BridgeBio Pharma logo with Healthcare background

HC Wainwright Reiterates "Buy" Rating for BridgeBio Pharma (NASDAQ:BBIO)

NASDAQ:BBIO
Read HC Wainwright Reiterates "Buy" Rating for BridgeBio Pharma (NASDAQ:BBIO)
908 Devices logo with Technology background

908 Devices (NASDAQ:MASS) Now Covered by Canaccord Genuity Group

NASDAQ:MASS
Read 908 Devices (NASDAQ:MASS) Now Covered by Canaccord Genuity Group
Centerspace logo with Real Estate background

Centerspace's (CSR) "Neutral" Rating Reiterated at Cantor Fitzgerald

NYSE:CSR
Read Centerspace's (CSR) "Neutral" Rating Reiterated at Cantor Fitzgerald

Featured Articles and Offers

Alert Categories

All Alerts